Payments in respect of Third Party Patents and Technology Sample Clauses

Payments in respect of Third Party Patents and Technology. If (a) LeukoSite reasonably determines that (i) a patent owned, held or licensed by a third party that is not an Affiliate of LeukoSite covers the development, manufacture, use or sale of a Product Candidate or a Related Compound or that development, manufacture, use or sale of a Product Candidate or a Related Compound infringes an issued and unexpired patent of a third party that is not an Affiliate of LeukoSite (each, a "Blocking Third Party Patent") or (ii) a patented or proprietary complementary technology owned by a third party is necessary for LeukoSite's development, manufacture, use or sale of a Product Candidate or a Related Compound (a "Complementary Technology"), and (b) LeukoSite in-licenses such Blocking Third Party Patent or Complementary Technology pursuant to terms requiring LeukoSite to make payments to such third party, then, subject to the provisions of Section 3.8(g)(v) below, fifty percent (50%) of the amount of any payments that LeukoSite is required to pay in connection with such in-licensed Blocking Third Party Patent or Complementary Technology shall be offset by LeukoSite against any and all Aggregate Contingent Consideration Payments that LeukoSite is required to pay pursuant to this Section 3.8 with respect to such Product Candidate or Related Compound, provided that in no event shall the amount of any LeukoSite Contingent Milestone Payment, Contingent Partner Licensing Payment or Contingent Royalty Payment that would otherwise be payable by LeukoSite pursuant to this Section 3.8 be reduced by more than fifty percent (50%) pursuant to this Section 3.8(g)(iii). In the event that LeukoSite shall in-license Complementary Technology, LeukoSite shall use commercially reasonable efforts to get the licensor of any such Complementary Technology to agree to indemnify LeukoSite from third party infringement claims arising from LeukoSite's use of such Complementary Technology.
AutoNDA by SimpleDocs
Payments in respect of Third Party Patents and Technology. If (a) ABI reasonably determines that (i) the use of Company Intellectual Property necessary for the manufacture, use or sale of a Product infringes a valid issued and unexpired patent of a third party that is not an Affiliate of ABI (each, a "Blocking Third Party Patent") or (ii) a complementary technology owned by a third party that is not an Affiliate of ABI is necessary for the use of Company Intellectual Property necessary for the manufacture, use or sale of a Product (a "Complementary Technology"), and (b) ABI in-licenses such Blocking Third Party Patent or Complementary Technology pursuant to terms requiring ABI to make payments to such third party, then fifty percent (50%) of the amount of any payments that ABI is required to pay in connection with such in-licensed Blocking Third Party Patent or Complementary Technology shall be offset by ABI against any and all amounts that ABI would otherwise be required to pay pursuant to Section 3.8(a) hereof (after giving effect to any other adjustments thereto pursuant to this Section 3.8(b)) with respect to such Product, provided that in no event shall any and all amounts that ABI would otherwise be required to pay pursuant to Section 3.8(a) hereof (after giving effect to any other adjustments thereto pursuant to this Section 3.8(b)) during any calendar quarter be reduced by more than fifty percent (50%) pursuant to this Section 3.8(b)(ii). ABI agrees that any in-license of any Blocking Third Party Patent or Complementary Technology pursuant to this Section 3.8(b)(ii) shall be on arms' length terms.

Related to Payments in respect of Third Party Patents and Technology

  • Infringement of Third Party Rights Each party shall promptly notify the other in writing of any allegation by a Third Party that the activity of either of the parties hereunder infringes or may infringe the intellectual property rights of such Third Party. Allergan shall have the first right but not the obligation to control any defense of any such claim involving alleged infringement of Third Party rights by Allergan’s activities under this Agreement at its own expense and by counsel of its own choice, and ACADIA shall have the right but not the obligation, at its own expense, to be represented in any such action by counsel of its own choice. If Allergan fails to proceed in a timely fashion with regard to such defense, ACADIA shall have the right but not the obligation to control any such defense of such claim at its own expense and by counsel of its own choice, and Allergan shall have the right but not the obligation, at its own expense, to be represented in any such action by counsel of its own choice. ACADIA shall have the first right but not the obligation to control any defense of any such claim involving alleged infringement of Third Party rights by ACADIA’s activities under this Agreement at its own expense and by counsel of its own choice, and Allergan shall have the right but not the obligation, at its own expense, to be represented in any such action by counsel of its own choice. If ACADIA fails to proceed in a timely fashion with regard to such defense, Allergan shall have the right but not the obligation to control any such defense of such claim at its own expense and by counsel of its own choice, and ACADIA shall have the right but not the obligation, at its own expense, to be represented in any such action by counsel of its own choice. Neither party shall have the right to settle any infringement action under this Section 10.5 in a manner that diminishes the rights or interests of the other party without the consent of such party.

  • Third Party Patent Rights If either Party desires to bring an opposition, action for declaratory judgment, nullity action, interference, declaration for non-infringement, reexamination or other attack upon the validity, title or enforceability of a Patent Right owned or controlled by a Third Party and having one or more claims that Cover the Compound or Product, or the use, sale, offer for sale or importation of the Compound or Product (except insofar as such action is a counterclaim to or defense of, or accompanies a defense of, a Third Party’s claim or assertion of infringement under Section 7.6, in which case the provisions of Section 7.6 shall govern), such Party shall so notify the other Party and the Parties shall promptly confer to determine whether to bring such action or the manner in which to settle such action. Provention shall have the exclusive right, but not the obligation, to bring, at its own expense and in its sole control, such action in the Territory. If Provention does not bring such an action in the Territory, within ninety (90) days of notification thereof pursuant to this Section 7.7(a) (or earlier, if required by the nature of the proceeding), MacroGenics shall have the right, but not the obligation, to bring, at MacroGenics’ own expense, such action. The Party not bringing an action under this Section 7.7(a) shall be entitled to separate representation in such proceeding by counsel of its own choice and at its own expense, and shall cooperate fully with the Party bringing such action. Any awards or amounts received in bringing any such action shall be first allocated to reimburse the initiating Party’s expenses in such action, and any remaining amounts shall be allocated between the Parties as provided in Section 7.5(e).

  • Third Party Patents If any Third Party claims that a patent it owns or controls claims any aspect of a Licensed Product or its manufacture, use or sale, the Party with notice of such claim shall notify the other Party promptly, and the Parties shall as soon as practicable thereafter discuss in good faith regarding the best response.

  • Third Party Intellectual Property Rights (a) In providing a Service, we may supply you with materials (including software) licensed by third parties.

  • Intellectual Property Rights and Indemnification Any intellectual property which originates from or is developed by a Party shall remain in the exclusive ownership of that Party. No license in patent, copyright, trademark or trade secret, or other proprietary or intellectual property right now or hereafter owned, controlled or licensable to a Party, is granted to the other Party or shall be implied or arise by estoppel. It is the responsibility of each Party to ensure at its own cost that it has obtained any necessary licenses in relation to intellectual property of third Parties used by it to receive any service or to perform its respective obligations under this Agreement.

  • Third Party Technology Customer is hereby notified that third parties have licensed certain technology to Company, which is contained in the Software. Notwithstanding anything herein to the contrary, Customer hereby consents to the disclosure of Customer’s identity, and such other terms of this Agreement as necessary, to such third party licensors for the purpose of enabling Company to comply with the terms and conditions of such third party licenses. Any such Customer information will be provided pursuant to an obligation of confidentiality and nondisclosure at least as stringent as that imposed by this Agreement.

  • Intellectual Property Rights Infringement HP will defend and/or settle any claims against Customer that allege that an HP-branded product or service as supplied under this Agreement infringes the intellectual property rights of a third party. HP will rely on Customer’s prompt notification of the claim and cooperation with our defense. HP may modify the product or service so as to be non-infringing and materially equivalent, or we may procure a license. If these options are not available, we will refund to Customer the amount paid for the affected product in the first year or the depreciated value thereafter or, for support services, the balance of any pre-paid amount or, for professional services, the amount paid. HP is not responsible for claims resulting from any unauthorized use of the products or services. This section shall also apply to deliverables identified as such in the relevant Support Material except that HP is not responsible for claims resulting from deliverables content or design provided by Customer.

  • INTELLECTUAL PROPERTY RIGHTS AND INDEMNITY 42.1 Save as granted under this Framework Agreement, neither the Authority nor the Supplier shall acquire any right, title or interest in the other's Pre-Existing Intellectual Property Rights.

  • INTELLECTUAL PROPERTY RIGHTS - INVENTION AND PATENT RIGHTS Unless otherwise agreed upon by NASA and AFRL, custody and administration of inventions made (conceived or first actually reduced to practice) under this IAA will remain with the respective inventing Party. In the event an invention is made jointly by employees of the Parties (including by employees of a Party's contractors or subcontractors for which the U.S. Government has ownership), the Parties will consult and agree as to future actions toward establishment of patent protection for the invention.

  • Third Party Intellectual Property 6.1 Unless otherwise expressly indicated, all Intellectual Property rights including, but not limited to, Copyright and Trademarks, in product images and descriptions belong to the manufacturers or distributors of such products as may be applicable.

Time is Money Join Law Insider Premium to draft better contracts faster.